Viatris, Inc. (VTRS)
16.88
-0.06
(-0.32%)
USD |
NASDAQ |
Sep 04, 16:00
16.88
0.00 (0.00%)
After-Hours: 19:19
Viatris Cash and Short Term Investments (Annual) : 1.454B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.454B |
| December 31, 2024 | 829.60M |
| December 31, 2023 | 1.080B |
| December 31, 2022 | 1.338B |
| December 31, 2021 | 935.00M |
| December 31, 2020 | 934.90M |
| December 31, 2019 | 600.20M |
| December 31, 2018 | 480.60M |
| December 31, 2017 | 569.40M |
| December 31, 2016 | 1.322B |
| December 31, 2015 | 1.343B |
| December 31, 2014 | 359.60M |
| December 31, 2013 | 420.79M |
| December 31, 2012 | 349.97M |
| December 31, 2011 | 415.02M |
| December 31, 2010 | 715.11M |
| December 31, 2009 | 456.04M |
| December 31, 2008 | 639.72M |
| December 31, 2007 | 575.56M |
| March 31, 2007 | |
| March 31, 2006 | 518.13M |
| March 31, 2005 | 808.08M |
| March 31, 2004 | 687.16M |
| March 31, 2003 | 686.81M |
| Date | Value |
|---|---|
| March 31, 2002 | 617.06M |
| March 31, 2001 | 284.90M |
| March 31, 2000 | 303.05M |
| March 31, 1999 | 259.72M |
| March 31, 1998 | 124.72M |
| March 31, 1997 | 140.03M |
| March 31, 1996 | 189.44M |
| March 31, 1995 | 179.86M |
| March 31, 1994 | 88.45M |
| March 31, 1993 | 98.25M |
| March 31, 1992 | 60.32M |
| March 31, 1991 | 37.48M |
| March 31, 1990 | 21.92M |
| March 31, 1989 | 29.86M |
| March 31, 1988 | 38.09M |
| March 31, 1987 | 26.24M |
| March 31, 1986 | 14.97M |
| March 31, 1985 | 5.92M |
| March 31, 1984 | 2.678M |
| March 31, 1983 | 1.227M |
| March 31, 1982 | 0.864M |
| March 31, 1981 | 0.039M |
| March 31, 1980 | 0.0741M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Pfizer Inc. | 13.60B |
| Eli Lilly & Co. | 7.268B |
| Merck & Co., Inc. | 14.69B |
| Bristol Myers Squibb Co. | 10.67B |
| Johnson & Johnson | 20.10B |